Citadel Advisors’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $61.4K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $411 | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $14K | Sell |
|
|||||
|
2022
Q1 | $143K | Sell |
|
|||||
|
2021
Q4 | $469K | Buy |
|
|||||
|
2021
Q3 | $623K | Buy |
|
|||||
|
2021
Q2 | $140K | Buy |
|
|||||
|
2021
Q1 | – | Hold |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $1.78M | Sell |
|
|||||
|
2020
Q2 | $12M | Sell |
|
|||||
|
2020
Q1 | $11.2M | Buy |
|
|||||
|
2019
Q4 | $14.2M | Buy |
|